Blogpost - REAplan now distributed in France by Dessintey
With this collaboration, Dessintey proposes a unified offer IVS3 + REAplan® for a complete and intensive upper limb rehabilitation.
Whether they are the result of a stroke, an orthopaedic trauma or chronic pain, partial or total upper limb deficiencies have a significant impact on the quality of life of patients: they cause difficulties in carrying out daily activities such as eating, washing, dressing, etc.
Upper limb rehabilitation calls for an understanding of the individual components of the movement:
- Action planning: Potential of actions – Intention & motor planification
- Motor execution: Performance of movement and biofeedback
Indeed, for many patients, motor performance is affected by an altered or non-existent movement command (body awareness, memory of motor functions, projection in time) and/or a difficulty in executing the movement (strength deficit, amplitude limits).
The combined IVS3 and REAplan® technologies constitute a complementary and innovative approach in the therapeutic arsenal for upper limb rehabilitation. They are based on four fundamental pillars:
- Early and intensive treatment
- Varied and complementary treatments and stimulations
- Biofeedbacks to reinforce learning
- Patient adherence and motivation
Feedback from therapists in the field has largely demonstrated the effectiveness and complementarity of this IVS3 + REAplan® combination. Both technologies aim to accelerate the patient’s return to autonomy, with innovative technologies promoting motor relearning and movement repetition.
Therefore, we are pleased to announce that the distribution of the REAplan® device will be handled by Dessintey in France. Together, we will be stronger to serve our clients across France, with a range of complementary products within a unified offer.
The Axinesis team will continue to market its REAtouch® and REAtouch® Lite devices directly.